Tumbler™

Tumbler™

One Campaign. Every Parameter. Optimised

Conventional antibody engineering is sequential, one parameter at a time. Tumbler™ does it all at once. Starting from one or a handful of lead clones, Tumbler™ builds a library of at least 500 million variants by shuffling all six CDRs simultaneously, then screens with bespoke panning strategies to optimise every objective in a single campaign.

One Campaign. Every Parameter. Optimised

Conventional antibody engineering is sequential, one parameter at a time. Tumbler™ does it all at once. Starting from one or a handful of lead clones, Tumbler™ builds a library of at least 500 million variants by shuffling all six CDRs simultaneously, then screens with bespoke panning strategies to optimise every objective in a single campaign.

One Campaign. Every Parameter. Optimised

Conventional antibody engineering is sequential, one parameter at a time. Tumbler™ does it all at once. Starting from one or a handful of lead clones, Tumbler™ builds a library of at least 500 million variants by shuffling all six CDRs simultaneously, then screens with bespoke panning strategies to optimise every objective in a single campaign.

What Tumbler™ optimises  

  • Affinity maturation — >5-fold improvement over parental demonstrated

  • Humanisation — reduce immunogenicity while expanding the lead series

  • Cross-reactivity induction — species cross-reactivity, bi-epitopic paratopes (2-in-1 binders to dissimilar targets)

  • Clinical profile enhancement — liability removal, thermostability, broaden IP coverage

What Tumbler™ optimises  

  • Affinity maturation — >5-fold improvement over parental demonstrated

  • Humanisation — reduce immunogenicity while expanding the lead series

  • Cross-reactivity induction — species cross-reactivity, bi-epitopic paratopes (2-in-1 binders to dissimilar targets)

  • Clinical profile enhancement — liability removal, thermostability, broaden IP coverage

What Tumbler™ optimises  

  • Affinity maturation — >5-fold improvement over parental demonstrated

  • Humanisation — reduce immunogenicity while expanding the lead series

  • Cross-reactivity induction — species cross-reactivity, bi-epitopic paratopes (2-in-1 binders to dissimilar targets)

  • Clinical profile enhancement — liability removal, thermostability, broaden IP coverage

Timeline

Multiparameter optimisation in as little as 4 months. Starts with a free pre-project risk assessment (~1 week).

Timeline

Multiparameter optimisation in as little as 4 months. Starts with a free pre-project risk assessment (~1 week).

Timeline

Multiparameter optimisation in as little as 4 months. Starts with a free pre-project risk assessment (~1 week).

The data  

257

unique binders from a single affinity maturation campaign (~70% hit rate)

28

clones with over 5-fold affinity improvement versus parental

>5-fold

affinity improvement on a clone previously matured at another CRO

>20

Tumbler™ campaigns completed across diverse targets and therapeutic areas

Data ownership

Clients own their Tumbler™ Library and all data generated, royalty-free. SAR data is optimal for ML training sets and AI-based optimisation models.

Data ownership

Clients own their Tumbler™ Library and all data generated, royalty-free. SAR data is optimal for ML training sets and AI-based optimisation models.

Data ownership

Clients own their Tumbler™ Library and all data generated, royalty-free. SAR data is optimal for ML training sets and AI-based optimisation models.

Fullspectrum Characterization

fullspectrum-characterization

0

AnyFormat Manufacturing

anyformat-manufacturing

0

DeepDesign Engineering

deepdesign-engineering

0

FunctionInsight Assays

functioninsight-assays

0

B-Cell Navigator

b-cell-navigator

0

Solutions

solutions

1

Platforms & Technologies

platforms-technologies

0

Why FJBio

why-fjbio

0

Events & Resources

events-resources

0

Company

company

0

About

about

0

Antibody Discovery

antibody-discovery

0

Protein Production

protein-production

0

AtomicLevel Cryo-EM

atomic-level-cryo-em

0

FastTrack IND

fasttrack-ind

0

Biologistics

biologistics

0

Leadership

leadership

0

Careers

careers

0

News & Insights

news-insights

0

Case Studies

case-studies

0

Fact Sheets

fact-sheets

0

CellCraft Solutions

cellcraft-solutions

0

Cryo-EM

cryo-em

0

Display Platforms

display-platforms

0

Events

events

0

Library Diversity

library-diversity

0

MultiPath Discovery

multipath-discovery

0

Publications & Posters

publications-posters

0

Resources

resources

0

Screening | Analytics | Data Engines

screening-analytics-data-engines

0

Single B-Cell Screening

single-b-cell-screening

0

The Antibody Series Conference

the-antibody-series-conference

0

Tumbler™

tumbler

0

Webinars

webinars

0

White papers

whitepapers

0

Contact Us

contact-us

0